Insulin Pump Maker Tandem Wins Dismissal of Shareholder Suit

A federal judge dismissed a shareholder lawsuit accusing Tandem Diabetes Care Inc. of hiding information about staffing shortages at doctors’ offices related to Covid-19 and other headwinds the insulin pump maker faced.

Tandem repeatedly warned investors in calls and filings with the Securities and Exchange Commission about adverse market conditions, Judge Marilyn Huff in the US District Court for the Southern District of California said in an opinion filed Tuesday.

Those conditions included the physician staffing shortages, customers having less money to spend on insulin pumps because of high unemployment and inflation, and more insulin pumps entering the market from ...